hVIVO plc (AIM:HVO)
London · Delayed Price · Currency is GBP · Price in GBX 6.70
+0.10 (1.52%)
At close: Mar 25, 2026
hVIVO Market Cap
hVIVO has a market cap or net worth of 45.58 million as of March 25, 2026. Its market cap has decreased by -59.15% in one year.
Market Cap
45.58M
Enterprise Value
37.00M
Revenue
54.47M
Ranking
n/a
PE Ratio
8.71
Stock Price
6.70
Market Cap Chart
Since July 1, 2019, hVIVO's market cap has increased from 17.24M to 45.58M, an increase of 164.45%. That is a compound annual growth rate of 15.54%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 24, 2026 | 44.90M | 4.76% |
| Dec 31, 2025 | 42.86M | -69.27% |
| Dec 31, 2024 | 139.48M | -13.68% |
| Dec 29, 2023 | 161.59M | 140.84% |
| Dec 30, 2022 | 67.09M | -56.52% |
| Dec 31, 2021 | 154.31M | -10.47% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Jul 1, 2019 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Scancell Holdings | 121.94M |
| 4basebio | 80.48M |
| Bioventix | 75.76M |
| Hemogenyx Pharmaceuticals | 58.86M |
| Ondine Biomedical | 55.85M |
| Faron Pharmaceuticals Oy | 51.52M |
| Poolbeg Pharma | 30.14M |
| ImmuPharma | 25.64M |